There are just 4 days to go until the 13th annual Canada Walks for Bladder Cancer and we are so excited to see you at one of our in-person walking events across the country! 

There’s still time to join us September 23th and 24th, so lace up your sneakers and let's walk together for bladder cancer patients across Canada.

Your participation in the 2023 walk contributes directly to these impactful initiatives, creating a future where bladder cancer is better understood, and treated, and, create a world where bladder cancer is just a memory.

We'd like to highlight and thank some of the wonderful people who are dedicating their time to the walk this September.

"Over the last 11 years, I have often benefited personally from the webinars and patient information meetings of Bladder Cancer Canada. I find it so important to continue to support this wonderful organization by participating in Canada Walks for Bladder Cancer each year and continuing to raise funds to support research aimed at finding a cure for bladder cancer and to ensure that patient and caregiver information continues to be available."

There is still time to Boost Your Impact to WIN!

Participants will receive 1 entry for every $300 raised towards their personal fundraising goal. The official winner will be announced Monday, September 25, 2023.

Bladder Cancer Canada, along with EMD Serono, are excited to announce the grant recipients of the 2023 Quality Improvement Grants for patients with advanced bladder cancer.

Two of the funded projects include:

To address this, we're creating a Financial Assistance and Resources Series with videos, 1-pagers, templates, and links, tailored for bladder cancer patients and caregivers in each province.

Your input is crucial. Do you have questions on coverage or disability application success? Are you knowledgeable in this area?

If you would like to join one of these groups, please email: info@bladdercancercanada.org

Cisplatin-based neoadjuvant chemotherapy before local treatment (i.e., resection or radical cystectomy) is the standard of care for patients with localized muscle-invasive urothelial carcinoma (MIUC) of the bladder. However, even with the addition of adjuvant nivolumab (an immune checkpoint inhibitor, or ICI), outcomes for patients are still far from optimal, with 25%-50% experiencing relapse and eventual death from their disease. Several clinical trials have been done to examine whether perioperative chemoimmunotherapy with another ICI, durvalumab, can improve outcomes for patients with MIUC. In a recent study of 57 MIUC patients, researchers found that the combination of neoadjuvant durvalumab with chemotherapy, followed by adjuvant durvalumab alone, achieved significantly high rates of event-free survival (EFS; i.e., time after treatment until progression, recurrence, metastases, or death occurs) and overall survival (OS) after 2 years. EFS and OS rates at 2 years were 76% and 85%, respectively, thus pointing toward a promising future for the treatment of MIUC with chemoimmunotherapy.

Date: October 17  

Time: 7-8pm ET 

Join us for an informative and sensitive webinar that delves into the vital topic of men’s sexual health after bladder cancer. Hosted by Dr. Jasmir G. Nayak, a Urologic Oncologist, Associate Professor at the University of Manitoba, and Co-founder of the Men’s Health Clinic Manitoba, this session will discuss the common sexual side effects after bladder cancer treatments and practical strategies to address the challenges that can arise in the realm of intimacy and relationships post-treatment.

In May we held our first in-person event post-COVID in Hamilton, ON. which included “Bladder Cancer in Octogenarians” presented by: Dr. Jehonathan Pinthus, MD, PhD, FRCSC. 

You can watch the recording HERE.

Volunteer Role: Walk Lead

Fun Fact: I love travelling and exploring the outdoors. Visiting some of the amazing National Parks in North America is on my bucket list.  

Passion Towards Volunteering for BCC: Volunteering with Bladder Canada Canada has really strengthened my sense of community. It’s inspiring seeing people join together to support this amazing cause, and I’m grateful for all I’ve learned through this experience. 

The annual BCC Volunteer Award window is opening October 1! 

Nominate them for a BCC Award! The window will be open October 1-November 30. Stay tuned for more details!  

If you're interested in volunteering, contact Theresa to learn more.

For more information and a complete list of bladder cancer support groups available, please visit: https://bladdercancercanada.org/en/get-support